Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07256236 |
| Consolidated Lead Sponsor | Fujian Cancer Hospital |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 89 participants (ESTIMATED) |
| Registered Start Date | 2026-01-28 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Fujian Cancer Hospital | Fuzhou, China | Open Hospital Dossier -> |
| ZhuJiang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| Guangxi Medical University Cancer Hospital | Nanning, China | Open Hospital Dossier -> |
| Qilu Hospital of Shandong University | Jinan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.